We are live on ! Find out more
DOVA

Dova Pharmaceuticals, Inc. Common Stock
DOVA

Delisted

DOVA was delisted on the 11th of November, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Dova Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 72 → 0 (-72)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $278M → $0 (-$278M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 72

Holders
–
Holders Change
-72
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
72
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$104M
2
AAM
Alpine Associates Management
Florida
-$39.7M
3
BlackRock
BlackRock
New York
-$27.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$16.6M
5
GKIM
GW&K Investment Management
Massachusetts
-$9.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
– -$104M -3,708,705 Closed
AAM
2
Alpine Associates Management
Florida
– -$39.7M -1,419,100 Closed
BlackRock
3
BlackRock
New York
– -$27.6M -987,298 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$16.6M -592,305 Closed
GKIM
5
GW&K Investment Management
Massachusetts
– -$9.24M -330,621 Closed
Renaissance Technologies
6
Renaissance Technologies
New York
– -$8.34M -298,400 Closed
Goldman Sachs
7
Goldman Sachs
New York
– -$7.14M -255,362 Closed
PAMP
8
Polar Asset Management Partners
Ontario, Canada
– -$5.59M -200,000 Closed
State Street
9
State Street
Massachusetts
– -$5.33M -190,818 Closed
Geode Capital Management
10
Geode Capital Management
Massachusetts
– -$4.73M -169,097 Closed
WIC
11
Water Island Capital
New York
– -$3.91M -140,000 Closed
Invesco
12
Invesco
Georgia
– -$3.62M -129,334 Closed
Northern Trust
13
Northern Trust
Illinois
– -$3.28M -117,207 Closed
BBA
14
Baker Bros. Advisors
New York
– -$2.86M -102,205 Closed
BGIM
15
Brandywine Global Investment Management
Pennsylvania
– -$2.69M -96,265 Closed
BCM
16
Bridgeway Capital Management
Texas
– -$2.46M -87,856 Closed
OAC
17
OMERS Administration Corp
Ontario, Canada
– -$2.33M -83,400 Closed
GF
18
Gabelli Funds
New York
– -$2.11M -75,500 Closed
UBS Group
19
UBS Group
Switzerland
– -$1.62M -58,035 Closed
Wells Fargo
20
Wells Fargo
California
– -$1.5M -53,628 Closed
Charles Schwab
21
Charles Schwab
California
– -$1.49M -53,310 Closed
Millennium Management
22
Millennium Management
New York
– -$1.46M -52,187 Closed
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
– -$1.4M -50,000 Closed
BC
24
Birchview Capital
Vermont
– -$1.4M -50,000 Closed
WAM
25
Weiss Asset Management
Massachusetts
– -$1.4M -50,000 Closed
1
2 3

DOVA Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Dova Pharmaceuticals, Inc. Common Stock (DOVA) for Q4 2019, worth a combined $0 — down 100% from $278M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DOVA and 0 opened new positions — a net loss of 72 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $104M sold.

  • 0 institutional investors held Dova Pharmaceuticals, Inc. Common Stock (DOVA) as of Q4 2019, down from 72 in Q3 2019.
  • Funds reported $0 of Dova Pharmaceuticals, Inc. Common Stock stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Dova Pharmaceuticals, Inc. Common Stock positions in Q4 2019 and 72 closed out, a net change of -72 holders.
  • The largest Dova Pharmaceuticals, Inc. Common Stock seller in Q4 2019 was Perceptive Advisors, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2019.